Galantamine Versus Placebo in Childhood Autism
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00252603|
Recruitment Status : Completed
First Posted : November 11, 2005
Last Update Posted : January 29, 2007
University of Medicine and Dentistry of New Jersey
National Alliance for Autism Research
Information provided by:
Rutgers, The State University of New Jersey
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||No date given|
|Estimated Study Completion Date :||April 2007|
Allin M, Matsumoto H, Santhouse AM, Nosarti C, AlAsady MH, Stewart AL, Rifkin L, Murray RM. Cognitive and motor function and the size of the cerebellum in adolescents born very pre-term. Brain. 2001 Jan;124(Pt 1):60-6.
Aman MG, Van Bourgondien ME, Wolford PL, Sarphare G. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. J Am Acad Child Adolesc Psychiatry. 1995 Dec;34(12):1672-81.
Aman MG, Singh NN, Stewart AW, Field CJ. Psychometric characteristics of the aberrant behavior checklist. Am J Ment Defic. 1985 Mar;89(5):492-502.
Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry. 1984 Oct;141(10):1195-202.
Birmaher B, Quintana H, Greenhill LL. Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry. 1988 Mar;27(2):248-51.
Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA. 2001 Jun 27;285(24):3093-9.
Ghaziuddin M, Tsai L, Ghaziuddin N. Fluoxetine in autism with depression. J Am Acad Child Adolesc Psychiatry. 1991 May;30(3):508-9.
Greenspan, S.I. & Wieder, S. Developmental patterns and outcomes in infants and children with disorders in relating and communicating A chart review of 200 cases of children with autistic spectrum diagnoses. J Dev Learning Disord, 1997;1:87-141.
Kern JK, Miller VS, Cauller PL, Kendall PR, Mehta PJ, Dodd M. Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder. J Child Neurol. 2001 Mar;16(3):169-73.
Martin A, Scahill L, Klin A, Volkmar FR. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use. J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):923-31.
Perry EK, Lee ML, Martin-Ruiz CM, Court JA, Volsen SG, Merrit J, Folly E, Iversen PE, Bauman ML, Perry RH, Wenk GL. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry. 2001 Jul;158(7):1058-66.
Ritvo ER, Mason-Brothers A, Freeman BJ, Pingree C, Jenson WR, McMahon WM, Petersen PB, Jorde LB, Mo A, Ritvo A. The UCLA-University of Utah epidemiologic survey of autism: the etiologic role of rare diseases. Am J Psychiatry. 1990 Dec;147(12):1614-21.
Steffenburg S. Neuropsychiatric assessment of children with autism: a population-based study. Dev Med Child Neurol. 1991 Jun;33(6):495-511.
Thal DJ, O'Hanlon L, Clemmons M, Fralin L. Validity of a parent report measure of vocabulary and syntax for preschool children with language impairment. J Speech Lang Hear Res. 1999 Apr;42(2):482-96.
Voelker SL, Shore DL, Brown-More C, Hill LC, Miller LT, Perry J. Validity of self-report of adaptive behavior skills by adults with mental retardation. Ment Retard. 1990 Oct;28(5):305-9.